Michael John Munchhof
57Patents
18h-index
44Co-inventors
84Inventor score
Filing activity: Feb 10, 2000 → Feb 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6492383B1 | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents | Human Necessities | 93 | Expired |
| US7199123B2 | Pyrazine compounds as transforming growth factor (TGF) compounds | Chemistry; Metallurgy | 58 | Expired |
| US6627754B2 | Pyrrolo[2,3-d]pyrimidine compounds | Human Necessities | 56 | Expired |
| US6962993B2 | Pyrrolo[2,3-d]pyrimidine compounds | Human Necessities | 54 | Expired |
| US8993555B2 | PRMT5 inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 47 | Active |
| US8940726B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 46 | Active |
| US8906900B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 44 | Active |
| US9221794B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 40 | Active |
| US9365555B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 37 | Active |
| US9266836B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 35 | Active |
| US9365519B2 | PRMT5 inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 34 | Active |
| US9388173B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 32 | Active |
| US7301023B2 | Chiral salt resolution | Chemistry; Metallurgy | 23 | Expired |
| US9604930B2 | Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 21 | Active |
| US9611257B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US6956041B2 | Pyrrolo[2,3-d]pyrimidine compounds | Human Necessities | 20 | Expired |
| US6696567B2 | Pyrrolo[2,3-d]pyrimidine compounds | Human Necessities | 20 | Expired |
| US7091208B2 | Pyrrolo[2,3-D]pyrimidine compounds | Human Necessities | 19 | Expired |
| US9675614B2 | PRMT5 inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 17 | Active |
| US9732072B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 16 | Active |
| USRE41783E1 | Pyrrolo[2,3-D]pyrimidine compounds | General | 16 | Active |
| US9777008B2 | PRMT5 inhibitors and uses thereof | Chemistry; Metallurgy | 15 | Active |
| US7432370B2 | Chiral salt resolution | Chemistry; Metallurgy | 15 | Expired |
| US8431597B2 | Benzimidazole derivatives | Chemistry; Metallurgy | 15 | Active |
| US7192963B2 | Pyrrolo[2,3-d]pyrimidine compounds | Human Necessities | 15 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.